Meta Pixel

News and Announcements

FishFrom announces exclusive partnership with Italian University over breakthrough aquaculture technology

  • Published August 26, 2022 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Atlantic Salmon RAS: Scotland’s Next Step

A strategic partnership between Scotland and Italy will jumpstart the production of a key species in Scotland. 

Atlantic salmon are Scotland’s most iconic fish. Over the years, farming of the species has greatly expanded. But with concerns over the environmental consequences of open net pens, an increasing number of land-based, recirculating aquaculture systems (RAS) are now emerging. 

Taking advantage of this opportunity is FishFrom Ltd based in Dunkeld, Perthshire. With more than 120 years’ experience between them, the team has been researching and designing RAS systems since 2012, with a view to supplying premium-quality farmed salmon with technology that minimises environmental impact and maximises animal welfare. 

Now, the company is due to commercialise a new RAS technology through a strategic partnership with the universities of Trento and Bologna and The Innovation Hub of Trentino (HIT) in Italy. 

Register Interest

New Partnership

FishFrom Ltd director and co-founder Andrew Robertson explains that a visit to the Freshwater Institute in West Virginia led to plans to establish a commercially viable opportunity to farm Atlantic salmon using RAS. Robertson and his team connected with the universities of Trento and Bologna through a collaboration with EIT food, a community that is part of the European Institute for Innovation and Technology (EIT), an independent EU body that promotes innovation and entrepreneurship across Europe.

Connect with the company and learn more about FishFrom by accessing their deal room here.

Register Interest

 

Capital Insights
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t

The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.

Capital Insights
Following the Billions: Where the Hyperscalers are Betting on the Future

The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.

Join over 45,000+ sophisticated investors

Join Now